PhaseBio Pharmaceuticals (PHAS) null Earnings

15MarConfirmed
May 20
Aug 20
Nov 20
Mar 21
-1.03
-0.81
-0.59
-0.37

Details

Expected EPS
-0.7
Actual EPS
-1.03
Surprise EPS
-0.33
Surprise Percent
+47.14%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -1.03 per share for .

0 Comments

Share your thoughts